Matthew Miessau Overview

  • Primary Position
  • Principal

  • Active Board Seats
  • 3

Matthew Miessau General Information

Biography

Mr. Matthew Miessau serves as Board Member at Clyde Biosciences. He serves as Principal at Epidarex Capital. He served as an Executive at MASA Life Science Venture. He joined Epidarex in 2014 and focuses on conducting due diligence on prospective fund investments as well as sourcing and analyzing opportunities for Epidarex's strategic investors. He is also currently an instructor at the NIH Foundation for Advanced Education in the Sciences (FAES), teaching Biomedical Business Development for Scientists. Prior to joining Epidarex, he was the Program Manager for the Georgetown University Center for Drug Discovery where he was responsible for managing the daily financial and research operations for the Center as well as developing the Center's annual budget and grant proposals. He holds an M.S. in biotechnology and a B.S. in biochemistry from Georgetown University.

Contact Information

Primary Position
Principal, Epidarex Capital
Education
Georgetown University, MS (Master of Science)
Georgetown University, BS (Bachelor of Science)
Gender
Male
Email
ma
Phone
+1 (301)
Address
  • 7910 Woodmont Avenue
  • Suite 1315
  • Bethesda, MD 20814
  • United States
+1 (301)

Matthew Miessau Positions (1)

Firm name Firm type Title Location Industry Since
Epidarex Capital Investor Principal Bethesda, MD Venture Capital

Matthew Miessau Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Clyde Biosciences Other Healthcare Technology Systems Privately Held (backing) Venture Capital-Backed Newhouse, United Kingdom
Epidarex Exeed Private Equity Privately Held (backing) Venture Capital-Backed Edinburgh, United Kingdom
Kodikaz Therapeutic Solutions Drug Discovery Privately Held (backing) Venture Capital-Backed New York, NY

Matthew Miessau Network (9)

Board Members (9)

Name Company Representing Location From
Elizabeth Roper Ph.D Epidarex Exeed Self Edinburgh, United Kingdom
Alan Johnston Clyde Biosciences Self Newhouse, United Kingdom
Epidarex Exeed Self Edinburgh, United Kingdom
Epidarex Exeed Self Edinburgh, United Kingdom
Kodikaz Therapeutic Solutions Epidarex Capital New York, NY

Matthew Miessau FAQs

  • Who is Matthew Miessau?

    Mr. Matthew Miessau serves as Board Member at Clyde Biosciences.

  • How much does Matthew Miessau typically invest?

    Matthew Miessau's median deal size is .

  • What is Matthew Miessau’s main position?

    Matthew Miessau’s primary position is Principal.

  • What are the contact details for Matthew Miessau?

    Matthew Miessau’s email address is ma and his phone number is +1 (301) .

  • How many active board seats does Matthew Miessau hold?

    Matthew Miessau holds 3 board seats including Clyde Biosciences, Epidarex Exeed, and Kodikaz Therapeutic Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »